Download free PDF

Pet Diabetes Care Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2025 – 2034

Report ID: GMI3777

Download Free PDF

Pet Diabetes Care Market Size

The global pet diabetes care market generated significant revenues in 2024 and is estimated to grow at a decent CAGR during 2025-2034, driven by increased incidence of diabetes among companion animals and growing advancements in medical technology. A 2023 report by the American Veterinary Medical Association (AVMA) stated that approximately 1 in 300 dogs and 1 in 230 cats in the United States had diabetes. The growth of the market is driven by rising pet ownership globally, increasing awareness of diabetes in pets, and advancements in treatment options.

The willingness of owners to expand their resources on their pets' health and well-being" along with improving alternatives for diabetes care has fueled the demand for specialized diabetes care products including insulin therapies and glucose monitoring devices. Furthermore, the increase in pet ownership, especially among millennials and Generation Z, is leading to more people looking to care for their pet's diabetes, particularly dogs and cats that are most impacted.
 

The market for pet diabetes care has flourished increasingly as the number of pets diagnosed with diabetes grows around the globe. Indeed, factors such as increasing pet adoption, increasing awareness around pet healthcare, and advances in veterinary care are driving the growth of the pet diabetes care market. In addition, the increasing trend of pet humanization in which pets are considered for family members, further drives pet owners to spend money (i.e. invest) in better care for their pets including caring for a chronic condition such as diabetes.
 

However, the market is limited because of the high expense related to pet diabetes care like constant insulin dosing, glucose testing, and veterinary appointments. In some geographic areas, these products may be less accessible due to high prices. Additionally, pet owners can also be confronted with the difficulties related to providing insulin and glucose testing for their pets.
 

Pet Diabetes Care Market Trends

The market is seeing some key developments and trends. One of the notable trends is the availability of practical and more effective glucose monitoring devices for pets. A significant part of pet diabetes management has been for owners and caregivers to monitor their pets' blood glucose through painful and tricky blood tests. With the development of continuous glucose monitors (CGMs) and advanced insulin pens, pet diabetes management has become easier and more accurate, increasing the chances of compliance by pet owners.
 

A large trend I've noticed is companies that are developing insulin therapies tailored to pets. There is a growing number of companies producing insulin products for companion animals, and this trend in insulin development will create products that are both more effective for diabetic pets and easier to use by their owners. Interestingly, the rising incidence of obesity in pets is evidence of the growing need for diabetes care solutions, as the overweight population of pets, by default, have a higher risk of developing diabetes. These trends indicate a higher sophisticated market maturity with products that are being designed to make the diabetes management experience as simple as possible and are user-friendly products for pet owners.
 

Pet Diabetes Care Market Analysis

The insulin therapy segment held a notable share in 2024 driven by a major part of diabetes treatment for pets, especially for diabetic dogs and cats. Diabetes therapy typically entails needing insulin injections to manage blood glucose levels, and in what is a crowded marketplace of pharmaceutical companies, some companies make insulin very specifically for animals. Insulin injections are regularly prescribed by veterinarians and can be administered at home by a pet owner after professional training. The main products in insulin therapy are long-acting insulins that treat diabetes in cats and dogs, such as Vetsulin (Merck Animal Health), and Prozinc (produced by Zoetis). The outlook for insulin therapy for pets is expected to remain strong as it will benefit from greater awareness associated with diabetes treatment in pets.
 

The glucose monitoring devices segment in the pet diabetes care market held robust growth in 2024. Monitoring glucose is an essential part of diabetes management and pet owners are choosing more accurate and less invasive glucose monitoring tools for their pets. Pet owners used to test blood glucose utilizing needles or lancets. This was inconvenient for the owner and uncomfortable for the pets. The development of continuous glucose monitors (CGMs) and more advanced blood glucose testing kits and methods is changing the monitoring landscape.
 

CGMs offer continuous glucose monitoring and timely reporting of glucose levels to the pet owner. Pet owners prefer CGMs because they can help detect changes in glucose levels and provide owners time to intervene when their pets run the risk of having poor glucose control. Advances in handheld glucose meters now allow pet owners to "one tap" glucose their pets in the comfort of their own homes. These meter solutions can ease the stress of blood sampling and increase comfort for both the pet and the owner.
 

The companion animals segment exhibited sustainable growth in 2024. The prevalence of diabetes is particularly high in older dogs and cats as they age and become overweight. Although dogs and cats have been diagnosed with diabetes for some time, the number of overweight pets has increased and subsequently, diabetes in companion animals has also increased. Due to their genetics, aging process, and increased number of companion animals that now carry an extra weight burden, more and more dogs and cats are being diagnosed with diabetes. Because many owners treat their companion animals like family, they are also more inclined to purchase diabetes management and care products to help their pets live a higher quality of life. The companion animal segment is in growth mode as both veterinarians and owners receive greater education on diabetes in companion animals.
 

United States pet diabetes care market generated notable revenues in 2024. The high prevalence of diabetes among pets within the United States is one of the key drivers for the overall demand for diabetes care products. According to the American Veterinary Medical Association (AVMA), the number of diabetic pets in the United States is on the rise, partly due to the increase in pet ownership.
 

In addition, the well-established veterinary landscape and high spending on pet healthcare unique to the United States is propelling the market. The high incidence of diabetes among pets is making pet owners more knowledgeable about the management of diabetes resulting in a greater willingness to spend money on high-quality treatment. Key market players such as Merck Animal Health, Zoetis, and Mars Petcare are also significant contributors in the growth of the market. As the pet care industry continues to grow and change, the U.S.  continues to be one of the largest markets for pet diabetes care products.
 

Pet Diabetes Care Market Share

Major players involved in the pet diabetes care industry include:

  • UltiMed Inc.
  • Zoetis
  • Becton
  • Merck & Co.
  • Boehringer Ingelheim Vetmedica Inc.
  • Dickinson and Company
     

Companies involved in the market are strengthening their position through product development and partnerships. Major players are investing in R&D to create improved insulin therapies, glucose monitoring products, and insulin delivery systems; companies are also making insulin administration more accessible. Companies are also using partnerships with animal health practitioners and veterinary clinics, to increase distribution and improve access to pet diabetes management products and services.
 

Companies are improving their marketing activities, focused on educating pet owners about diabetes management by targeting advertising campaigns, including a mix of initial virtual webinars and live veterinary outreach. Companies have expanded to improve their geographic reach and take an interest in emerging markets to participate in pet healthcare service regions' growth.
 

Pet Diabetes Care Industry News

  • In April 2025, Universal Biosensors (UBI), a global leader in handheld electrochemical diagnostic technology, released a new consumer-configured PETRACKR® Blood Glucose Monitoring System Starter Pack. This product was designed for pet owners who were managing diabetes in their cats and dogs.
     
  • In November 2023, Boehringer Ingelheim, a global leader in animal health, received marketing authorization from the European Commission for SENVELGO®. This approval marked a significant milestone for the treatment of feline diabetes in Europe.

 

Authors: Mariam Faizullabhoy
Authors: Mariam Faizullabhoy ,
Trust Factor 1
Trust Factor 2
Trust Factor 1
Top
We use cookies to enhance user experience. (Privacy Policy)